Dog Vaccines Market Outlook 2024: Exclusive Report By The Business Research Company | Bayer AG, Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Heska Corporation

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2269

The Business Research Company offers in-depth market insights through Dog Vaccines Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The dog vaccines market size has grown strongly in recent years. It will grow from $3.43 billion in 2023 to $3.64 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to innovative vaccination protocols, zoonotic disease awareness, globalization and travel, educational campaigns, research and vaccine development, veterinary practice evolution..

The dog vaccines market size is expected to see strong growth in the next few years. It will grow to $4.76 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing pet adoption rates, health consciousness among pet owners, government regulations and mandates, rising humanization of pets, prevalence of canine diseases.. Major trends in the forecast period include pet insurance and healthcare plans, availability and accessibility, customized vaccination protocols, changing disease patterns, development of novel vaccines..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=8443&type=smp

Market Segmentation:
The dog vaccines market covered in this report is segmented -

1) By Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines
2) By Route Of Administration: Subcutaneous, Intramuscular, Intranasal
3) By Application: Below 6 Months, Above 6 Months

Major Driver - Surge In Pet Dog Adoption Ignites Demand And Fostering Growth In The Dog Vaccines Market
The rise in the adoption of pet dogs is expected to propel the dog vaccines market going forward. A pet dog refers to a companion animal that is domesticated or tamed and lives within a home. A dog vaccine is an injection that is given to dogs in series starting at the puppy stage and continuing into adulthood. This vaccine stimulates the immune system which helps dogs to encounter microorganisms and not get sick or have less severe symptoms. For instance, according to the National Pet Owners Survey by the American Pet Products Association 2021-2022, a US-based not-for-profit industry association, 70% of households in the United States owned a pet, which was equal to 90.5 million homes. Out of this, a total of 69 million U.S. households owned a dog as a pet, which was the highest compared to other animals as pets. Thus, the rise in the adoption of pet dogs is driving the growth of the dog vaccines market.

Competitive Landscape:
Major companies operating in the dog vaccines market report are Bayer AG, Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Heska Corporation, Merck & Co. Inc., Virbac Animal Health Pvt. Ltd., Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Sanofi S.A., CyMedica Orthopedics Inc., Creative Biolabs Inc., Meiji Holdings Co. Ltd., Bioveta A.S., Phibro Animal Health Corporation, Hester Biosciences Limited, High Speed Digieal Processor Architecture Pvt. Ltd., Dechra Pharmaceuticals plc, Idexx Laboratories Inc., Norbrook Inc., Biogenesis Bago SA, Vaxxinova India Private Limited, Bimeda Animal Health Ltd., Lohmann Animal Health GmbH, Biovac Ltd., Zenex Animal Health India Pvt. Ltd., Instituto Rosenbusch S A, Pfizer Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

Top Trend - Introduction Of Mucosal-Protected Oral Vaccine Revolutionizes Canine Immunization Technology
Technological advancement is a key trend gaining popularity in the dog vaccines market. Major companies operating in the dog vaccines market are advancing toward the use of novel technology for vaccine development. For instance, in September 2022, Merck Animal Health, a US-based company providing veterinary pharmaceuticals, vaccines, and technology solutions, launched Nobivac Intra-Trac Oral BbPi, the first oral vaccine with mucosal protection and easy oral administration. It is used for the vaccination of healthy dogs aged 7 weeks or older against canine parainfluenza virus and Bordetella bronchiseptica. Additionally, it includes the novel technology, Immuno-Mist-R technology by Intervet, a Merck & Co subsidiary. This revolutionary technology, Immuno-Mist-RTM, dramatically increases mucosal surface area contact.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Dog Vaccines Market Characteristics
3. Dog Vaccines Market Trends And Strategies
4. Dog Vaccines Market - Macro Economic Scenario
5. Dog Vaccines Market Size And Growth
…..
27. Dog Vaccines Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.